History

Experience MPLN

Celebrating more than 30 years

2016

LIS Blue verion 7.0

Released 4th Generation web-enabled LIS; Permitting global access

2015

ISO15189 accreditation

ISO15189 accreditation obtained making MPLN 7th laboratory in USA to obtain this global distinction; Implemented NGS platforms illumina® MiSeqDx® and Thermo Fisher® PGM® Ion Torrent. Launched NGS assays for Cystic Fibrosis 139, CFTR gene and Solid Tumor NGS Panels. Invested in digital PCR.

2014

Genomic Solutions Division and Next Generation Sequencing

Genomic Solutions Division and Next Generation Sequencing technology launched; purchased 1st first FDA approved illumina MiSeqDX system sold in the US; Invested in 10 color flow cytometry with purchase of Beckman Coulter Navios® flow cytometry systems. Implemented Partners Program with first two large, integrated oncology practices.

2013

Pathology Partnerships Program

Pathology Partnerships Program implementation; Purchased Gen-Probe's PANTHER® System to expand testing for STD's Trichomonas Vaginalis and enable random access loading

2012

IT Infrastructure

MPLN began building the IT infrastructure and colocation facility to support our Next-Generation Sequencing efforts. Modern and mobile-friendly websites were developed for both MPLN and Geneuity, as well as Indigo, the iOS app component of our LIS.

GET IN TOUCH

Have questions?

Sed imperdiet, ante in porta ultrices, orci metus consequat lacus, ac viverra magna odio at dui. Sed id congue velit, nec gravida urna. In vestibulum nibh magna, at dapibus est molestie vulputate.

Send us an enquiry

+1-800-932-2943